Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Practical Value of IDUS in Patients With High Risk of Recurrence of Common Bile Duct Stones After ERCP Lithotomy

NCT06265311 is registered in ClinicalTrials.gov with Shanghai Municipal Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT06265311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06265311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Practical Value of IDUS in Patients With High Risk of Recurrence of Common Bile Duct Stones After ERCP Lithotomy
Lead sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Completed
Start date
November 2, 2021
Completion date
April 16, 2026
Enrollment
248 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiopancreatography, endoscopic retrograde, choledocholithiasis, ultrasonography